ArticleScientific reports2025

Atorvastatin negatively regulates MAPK pathway in vitro to inhibit proliferation, migration, and invasion of hepatocellular carcinoma cells.

Yuhua Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.